Assess respiratory and cardiac history before propranolol.
Absolute: severe asthma, bradycardia, heart block, uncompensated heart failure. Relative: diabetes (hypoglycemia masking), depression, peripheral vascular disease.
Nonselective beta blockade can provoke life-threatening bronchoconstriction; reserve therapy for alternative agents in reactive airway disease.
Propranolol slows AV nodal conduction and can precipitate symptomatic heart block in susceptible patients.
Negative inotropic effects worsen low-output states; stabilise circulation before considering beta-blockade.
Propranolol masks adrenergic warning signs of hypoglycemia and prolongs recovery; emphasise glucose monitoring and caregiver education.
Beta-blockade may exacerbate peripheral ischemia; monitor for cold extremities or choose a vasodilatory alternative.
Extensive hepatic metabolism raises drug exposure in liver disease; initiate lower doses and titrate cautiously.
Additive AV nodal blockade increases bradyarrhythmia risk; adjust dosing and monitor ECG when combinations are unavoidable.